
Join to View Full Profile
5169 S Cottonwood StSte 303Salt Lake City, UT 84107
Phone+1 801-507-3750
Dr. Gravbrot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicholas Gravbrot is a radiation oncologist based in Salt Lake City, UT. He graduated from the University of Arizona College of Medicine in 2021. His recent publications focus on various aspects of cancer treatment and outcomes, featuring research on radiotherapy, survival outcomes in endometrial cancer, and gene expression in glioblastoma. His work has been published in reputable journals such as World Neurosurgery, European Journal of Cancer, International Journal of Molecular Sciences, and Journal of Clinical Neuroscience.
Education & Training
- University of Arizona College of MedicineClass of 2021
Certifications & Licensure
- UT State Medical License 2022 - 2026
Publications & Presentations
PubMed
- Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Gra...Christopher R Weil, Calvin B Rock, Vikren Sarkar, Nicholas Gravbrot, Felicia H Lew
American Journal of Clinical Oncology. 2025-04-23 - Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma.Nicholas Gravbrot, Calvin B Rock, Christopher R Weil, Christian B Rock, Lindsay M Burt
World Neurosurgery. 2024-08-01 - Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics ...Nicholas Gravbrot, Christopher R Weil, Cristina M DeCesaris, David K Gaffney, Gita Suneja
European Journal of Cancer. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: